Astonea Labs

Who are the top shareholders of the Astonea Labs?

Astonea Labs is primarily owned by its promoters, who hold the majority of shares with no pledged holdings. There are no mutual funds, foreign institutional investors, or notable individual public shareholders involved.

Astonea Labs is primarily owned by its promoters, who hold the majority of the shares. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares. Additionally, there are no notable individual investors or public shareholders listed. This indicates a concentrated ownership structure primarily focused within the promoter group.

Has Astonea Labs declared dividend?

No Dividend History Available

How has been the historical performance of Astonea Labs?

Astonea Labs has shown gradual profitability improvement over the past three years, with a profit before tax rising from 0.00 Cr in March 2022 to 5.00 Cr in March 2024. Cash flow from operating activities turned positive at 4.00 Cr in March 2024, while cash flow from investing activities remained negative.

Answer:<BR>The historical performance of Astonea Labs shows a gradual improvement in profitability over the past three years, despite the absence of standalone annual results and balance sheet data.<BR><BR>Breakdown:<BR>In the cash flow results, Astonea Labs reported a profit before tax of 5.00 Cr in March 2024, a significant increase from 1.00 Cr in March 2023 and up from 0.00 Cr in March 2022. Adjustments remained stable at 6.00 Cr for both March 2024 and March 2023, while it was slightly lower at 5.00 Cr in March 2022. Changes in working capital showed a decrease in negative values, with -7.00 Cr in both March 2024 and March 2023, compared to -10.00 Cr in March 2022. Consequently, cash flow after changes in working capital improved to 4.00 Cr in March 2024, up from 0.00 Cr in March 2023 and a negative 4.00 Cr in March 2022. Cash flow from operating activities also turned positive at 4.00 Cr in March 2024, contrasting with -1.00 Cr in March 2023 and -4.00 Cr in March 2022. However, cash flow from investing activities was negative, amounting to -7.00 Cr in March 2024, compared to -3.00 Cr in the previous two years. Cash flow from financing activities decreased to 3.00 Cr in March 2024 from 4.00 Cr in March 2023 and 8.00 Cr in March 2022. Overall, the net cash inflow/outflow remained at 0.00 Cr for all three years, indicating no change in cash position.

Who are the peers of the Astonea Labs?

Astonea Labs' peers include Coral Labs, Bafna Pharma, Syschem (India), Aarey Drugs, Panch.Organics, Krebs Biochem, Auro Labs, Bal Pharma, BDH Industries, and Tyche Industries. In terms of management risk, growth, and capital structure, Auro Labs and Coral Labs stand out positively, while Astonea Labs shows average performance in these areas.

Peers: The peers of Astonea Labs are Coral Labs., Bafna Pharma., Syschem (India), Aarey Drugs, Panch.Organics, Krebs Biochem, Auro Labs., Bal Pharma, BDH Industries, and Tyche Industries.<BR><BR>Quality Snapshot: Excellent management risk is observed at Auro Labs. and BDH Industries, while Average management risk is found at Aarey Drugs, Bal Pharma, and Astonea Labs, and the rest. Below Average management risk is noted at Coral Labs., Bafna Pharma., and Syschem (India). In terms of Growth, Good growth is seen at Coral Labs., Bafna Pharma., Astonea Labs, and Bal Pharma, while Average growth is noted at Syschem (India) and Below Average growth is found at Aarey Drugs, Panch.Organics, and the rest. For Capital Structure, Excellent capital structure is observed at Coral Labs. and Panch.Organics, Good capital structure is noted at Bafna Pharma. and Auro Labs., while Below Average capital structure is found at Astonea Labs, Bal Pharma, and the rest.<BR><BR>Return Snapshot: Auro Labs. has the highest 1-year return at 68.93%, while Panch.Organics has the lowest at -45.84%. Astonea Labs.' 1-year return is not available for comparison. Additionally, the six-month returns for Coral Labs., Panch.Organics, Bal Pharma, and BDH Industries are negative.

What does Astonea Labs do?

Astonea Labs Ltd is a Micro Cap company in the Pharmaceuticals & Biotechnology industry, with a market cap of INR 188 Cr. It has no recent sales or profit reports, a P/E ratio of 34.00, and a high debt-equity ratio of 3.51.

Overview: <BR>Astonea Labs Ltd operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Micro Cap company.<BR><BR>History: <BR>The incorporation year and any status changes are not provided. There are no sales and profit reports available for the latest quarter.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 188 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 34.00 <BR>Industry P/E: 37 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 3.51 <BR>Return on Equity: 44.70% <BR>Price-to-Book: 15.55<BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: Not available. <BR>Email: Not available. <BR>Website: Not available.

How big is Astonea Labs?

As of 24th July, Astonea Labs Ltd has a market capitalization of 187.00 Cr, classifying it as a Micro Cap company. Recent quarterly performance data, including Net Sales and Net Profit, is unavailable, while the balance sheet for March 2024 shows Shareholder's Funds of 11.97 Cr and Total Assets of 80.89 Cr.

As of 24th July, Astonea Labs Ltd has a market capitalization of 187.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent quarterly performance data is not available, so there are no figures for Net Sales or Net Profit for the latest four quarters.<BR><BR>The reporting period for the balance sheet is March 2024, with Shareholder's Funds amounting to 11.97 Cr and Total Assets valued at 80.89 Cr.

Is Astonea Labs overvalued or undervalued?

As of August 28, 2025, Astonea Labs is considered very expensive with a PE ratio of 34.32, significantly higher than its peers, indicating overvaluation and underperformance, as it has declined 3.48% recently compared to a 2.34% drop in the Sensex.

As of 28 August 2025, Astonea Labs' valuation grade has moved from fair to very expensive, indicating a significant shift in its market perception. The company is currently overvalued, with a PE ratio of 34.32, a Price to Book Value of 15.34, and an EV to EBITDA of 14.93. These ratios suggest that the stock is trading at a premium compared to its earnings and book value.<BR><BR>In comparison to its peers, Astonea Labs' PE ratio is higher than Sun Pharma's 33.18 and significantly above Cipla's attractive PE of 23.65. The PEG ratio of Astonea Labs stands at 0.00, which is unusual and raises concerns about future growth expectations. Recent stock performance shows a decline of 3.48% over the past week, while the Sensex fell only 2.34%, reinforcing the notion that Astonea Labs is not only overvalued but also underperforming relative to the broader market.

When is the next results date for Astonea Labs?

Astonea Labs will announce its results on 10 November 2025.

Astonea Labs is scheduled to declare its results on 10 November 2025.

Why is Astonea Labs Ltd falling/rising?

As of 17-Mar, Astonea Labs Ltd's stock price is Rs 154.95, reflecting a 2.48% increase. This rise is supported by increased investor interest and a strong intraday performance, despite the stock trading below its longer-term moving averages.

As of 17-Mar, Astonea Labs Ltd's stock price is rising, currently at Rs 154.95, reflecting a change of Rs 3.75 or 2.48%. This increase can be attributed to several factors observed today. The stock opened with a gain of 2.48%, reaching an intraday high of Rs 154.95, and has maintained this price without fluctuation. Additionally, Astonea Labs has outperformed its sector by 2.2%, indicating stronger performance relative to its peers.<BR><BR>Investor participation has also increased, with a delivery volume of 6,000 shares on 16 March, which is a 3.45% rise compared to the 5-day average. This suggests growing interest among investors. However, it is important to note that despite today's positive movement, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a longer-term downward trend. Nonetheless, the current day's performance and rising investor participation are contributing to the stock's upward movement today.

Why is Astonea Labs Ltd falling/rising?

As of 18-Mar, Astonea Labs Ltd's stock price is stable at Rs 154.95, with a recent decline of 2.55% over the past week and 5.23% year-to-date. Despite today's positive opening and increased investor interest, the stock remains below key moving averages, indicating a bearish trend.

As of 18-Mar, Astonea Labs Ltd's stock price is currently stable at Rs 154.95, showing no change (0.00%). Despite this stability, the stock has experienced a decline of 2.55% over the past week and a slight decrease of 0.03% over the past month. Year-to-date, the stock has fallen by 5.23%, while the benchmark Sensex has also seen a decline of 9.99% during the same period.<BR><BR>Today, the stock opened with a gain of 2.48%, reaching an intraday high of Rs 154.95, indicating some positive momentum. Additionally, the stock has outperformed its sector by 2.2% today, which suggests a relative strength compared to its peers. There has been a rise in investor participation, with delivery volume increasing by 3.45% against the 5-day average, indicating growing interest among investors.<BR><BR>However, it is important to note that Astonea Labs is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which typically signals a bearish trend. Furthermore, the stock has shown erratic trading patterns, having not traded on 2 out of the last 20 days, which may contribute to uncertainty among investors.<BR><BR>In summary, while there are some positive indicators today, such as the opening gain and increased investor participation, the overall trend shows a decline in the stock's price over the longer term, influenced by its performance relative to moving averages and recent trading activity.

Why is Astonea Labs Ltd falling/rising?

As of 19-Mar, Astonea Labs Ltd's stock price is declining, currently at 154.90, with a year-to-date drop of -5.26%. The stock is underperforming against the Sensex and is trading below its moving averages, indicating a bearish trend and decreased investor participation.

As of 19-Mar, Astonea Labs Ltd's stock price is falling, as indicated by a current price of 154.90, which reflects a change of -0.05 (-0.03%). The stock has underperformed compared to the benchmark Sensex, with a 1-week decline of -2.58% against the Sensex's -2.40%. Over the past month, Astonea Labs has also shown a slight decline of -0.77%, while the Sensex has significantly outperformed with a drop of -10.05%. Year-to-date, the stock is down -5.26%, while the Sensex has decreased by -12.92%.<BR><BR>Additionally, the stock is trading lower than its moving averages across various periods, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. The sector performance has not been favorable either, with the Pharmaceuticals & Drugs sector falling by -2.13%. Furthermore, there has been a notable decrease in investor participation, with delivery volume on 17 March dropping by -79.17% compared to the 5-day average. This erratic trading behavior, where the stock did not trade on 3 out of the last 20 days, further contributes to the negative sentiment surrounding Astonea Labs Ltd.

Why is Astonea Labs Ltd falling/rising?

As of 20-Mar, Astonea Labs Ltd's stock price is at 150.00, down 3.16% and has underperformed its sector. The stock has seen a total decline of 5.66% over the past week and is trading below all key moving averages, indicating a bearish trend and decreased investor confidence.

As of 20-Mar, Astonea Labs Ltd's stock price is falling, currently at 150.00, which reflects a decrease of 4.9 points or 3.16%. The stock has underperformed its sector by 4.86% today and has been on a consecutive decline for the last two days, accumulating a total loss of 3.19% during this period. Additionally, the stock opened with a loss of 3.16% and reached an intraday low of Rs 150, indicating a lack of upward momentum.<BR><BR>The stock's performance over the past week shows a decline of 5.66%, while it has also fallen 3.91% over the past month. Year-to-date, the stock is down 8.26%. Furthermore, Astonea Labs is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend. <BR><BR>Investor participation has also decreased significantly, with delivery volume dropping by 56.52% compared to the 5-day average. This decline in trading activity, combined with the stock's consistent underperformance against the benchmark Sensex, which has only decreased by 0.04% in the same week, indicates a lack of confidence among investors, contributing to the stock's falling price.

Why is Astonea Labs Ltd falling/rising?

As of 23-Mar, Astonea Labs Ltd's stock price is at 150.00, unchanged from the previous day, but has declined 3.19% over the last two days and is trading below all key moving averages, indicating a bearish trend and decreased investor confidence.

As of 23-Mar, Astonea Labs Ltd's stock price is currently at 150.00, showing no change from the previous day. However, the stock has been experiencing a downward trend, having underperformed its sector by 4.86% today and falling consecutively for the last two days, resulting in a total decline of 3.19% during this period. The stock opened with a loss of 3.16% and touched an intraday low of Rs 150, indicating a lack of upward momentum.<BR><BR>Additionally, Astonea Labs is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which suggests a bearish trend. Investor participation has also decreased significantly, with delivery volume dropping by 56.52% compared to the 5-day average. This decline in trading activity further reflects a lack of confidence among investors, contributing to the stock's falling price. Overall, these factors indicate that Astonea Labs Ltd is currently facing downward pressure in its stock price.

Why is Astonea Labs Ltd falling/rising?

As of 24-Mar, Astonea Labs Ltd's stock price is rising to Rs 154.00, up 2.67%, but it has declined 0.61% over the past week and 3.75% over the month, indicating broader challenges despite today's positive movement. Reduced investor participation and erratic trading patterns further complicate the outlook.

As of 24-Mar, Astonea Labs Ltd's stock price is rising, currently at Rs 154.00, reflecting a change of 4.0 (2.67%) upward. This increase is notable as the stock has outperformed its sector by 1.55% today. Additionally, the stock reached an intraday high of Rs 154, indicating positive momentum within the trading day.<BR><BR>However, it is important to consider the broader context of the stock's performance. Over the past week, Astonea Labs has experienced a slight decline of 0.61%, and its performance over the past month shows a decrease of 3.75%. Year-to-date, the stock is down by 5.81%. Despite these declines, the current rise today suggests a temporary rebound or positive sentiment among investors, even as the stock is trading below its moving averages across various time frames.<BR><BR>Moreover, there has been a significant drop in investor participation, with delivery volume falling by 78.26% compared to the 5-day average, which could indicate a lack of sustained interest from investors. This erratic trading pattern, where the stock did not trade on 2 out of the last 20 days, further complicates the outlook.<BR><BR>In summary, while Astonea Labs Ltd's stock is experiencing a rise today, the overall trend indicates challenges, including recent declines and reduced investor activity.

Why is Astonea Labs Ltd falling/rising?

As of 25-Mar, Astonea Labs Ltd's stock price is rising to 157.00, up 2.28%. This increase is driven by strong trading activity, improved investor participation, and a recent outperformance against its sector.

As of 25-Mar, Astonea Labs Ltd's stock price is rising, currently at 157.00, reflecting an increase of 3.5 (2.28%). This upward movement is supported by several factors. The stock has outperformed its sector by 0.39% today and has experienced consecutive gains over the last two days, accumulating a total return of 4.67% during this period. Additionally, the stock reached an intraday high of Rs 159, indicating strong trading activity.<BR><BR>Investor participation appears to be increasing, as evidenced by a delivery volume of 4,000 shares on 24 March, which is an 11.11% rise compared to the 5-day average delivery volume. Furthermore, the stock's performance over the past week shows a gain of 1.32%, contrasting with a decline in the benchmark Sensex, which fell by 1.87%. <BR><BR>While the stock has shown some volatility, with erratic trading patterns noted, the overall trend today indicates a positive sentiment among investors, contributing to the rise in its stock price.

Which are the latest news on Astonea Labs?